These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20452543)

  • 1. Editorial comment: losartan-based medical therapy for aneurysm disease.
    Elefteriades JA
    Cardiol Clin; 2010 May; 28(2):287-8. PubMed ID: 20452543
    [No Abstract]   [Full Text] [Related]  

  • 2. Is losartan the true panacea for aneurysm disease? CON.
    Danyi P; Jovin IS
    Cardiol Clin; 2010 May; 28(2):279-85. PubMed ID: 20452542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is losartan the drug for all seasons?
    Ramirez F; Rifkin DB
    Curr Opin Pharmacol; 2012 Apr; 12(2):223-4. PubMed ID: 22445547
    [No Abstract]   [Full Text] [Related]  

  • 4. Is losartan the true panacea for aneurysm disease? PRO.
    Collins MJ; Elefteriades JA
    Cardiol Clin; 2010 May; 28(2):273-7. PubMed ID: 20452541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment: does medical therapy for thoracic aortic aneurysms really work? Are beta-blockers truly indicated?
    Elefteriades JA
    Cardiol Clin; 2010 May; 28(2):271-2. PubMed ID: 20452540
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of angiotensin receptor-1 blockade on electromechanical changes induced by left ventricular hypertrophy and its regression.
    Gray RP; Turner MA; Sheridan DJ; Fry CH
    Cardiovasc Res; 2007 Feb; 73(3):539-48. PubMed ID: 17174288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan for treatment of psychogenic polydipsia.
    Webber MA; Ofalabi I; Mahmud W; Herron MS; Shekhar A
    Ann Pharmacother; 2004 Oct; 38(10):1750-1. PubMed ID: 15340131
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy.
    Cardiovasc J Afr; 2009; 20(4):265. PubMed ID: 19701543
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis.
    Price A; Lockhart JC; Ferrell WR; Gsell W; McLean S; Sturrock RD
    Arthritis Rheum; 2007 Feb; 56(2):441-7. PubMed ID: 17265479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin II receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits].
    Antelava NA; Gongadze NV; Gogolauri MI; Kezeli TD; Pachkoriia KZ
    Georgian Med News; 2007 Sep; (150):57-60. PubMed ID: 17984566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.
    Winkelmayer WC; Zhang Z; Shahinfar S; Cooper ME; Avorn J; Brenner BM
    Diabetes Care; 2006 Oct; 29(10):2210-7. PubMed ID: 17003295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
    Fossum E; Moan A; Kjeldsen SE; Devereux RB; Julius S; Snapinn SM; Edelman JM; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Dahlöf B;
    J Am Coll Cardiol; 2005 Sep; 46(5):770-5. PubMed ID: 16139123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR
    Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
    Nattel S
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.